Kinga M Bujakowska1, Mark Consugar1, Emily Place1, Shyana Harper2, Jaclyn Lena1, Daniel G Taub1, Joseph White1, Daniel Navarro-Gomez1, Carol Weigel DiFranco2, Michael H Farkas1, Xiaowu Gai1, Eliot L Berson3, Eric A Pierce3. 1. Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States. 2. Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States. 3. Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States.
Abstract
PURPOSE: Patients with Usher syndrome type I (USH1) have retinitis pigmentosa, profound congenital hearing loss, and vestibular ataxia. This syndrome is currently thought to be associated with at least six genes, which are encoded by over 180 exons. Here, we present the use of state-of-the-art techniques in the molecular diagnosis of a cohort of 47 USH1 probands. METHODS: The cohort was studied with selective exon capture and next-generation sequencing of currently known inherited retinal degeneration genes, comparative genomic hybridization, and Sanger sequencing of new USH1 exons identified by human retinal transcriptome analysis. RESULTS: With this approach, we were able to genetically solve 14 of the 47 probands by confirming the biallelic inheritance of mutations. We detected two likely pathogenic variants in an additional 19 patients, for whom family members were not available for cosegregation analysis to confirm biallelic inheritance. Ten patients, in addition to primary disease-causing mutations, carried rare likely pathogenic USH1 alleles or variants in other genes associated with deaf-blindness, which may influence disease phenotype. Twenty-one of the identified mutations were novel among the 33 definite or likely solved patients. Here, we also present a clinical description of the studied cohort at their initial visits. CONCLUSIONS: We found a remarkable genetic heterogeneity in the studied USH1 cohort with multiplicity of mutations, of which many were novel. No obvious influence of genotype on phenotype was found, possibly due to small sample sizes of the genotypes under study. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE:Patients with Usher syndrome type I (USH1) have retinitis pigmentosa, profound congenital hearing loss, and vestibular ataxia. This syndrome is currently thought to be associated with at least six genes, which are encoded by over 180 exons. Here, we present the use of state-of-the-art techniques in the molecular diagnosis of a cohort of 47 USH1 probands. METHODS: The cohort was studied with selective exon capture and next-generation sequencing of currently known inherited retinal degeneration genes, comparative genomic hybridization, and Sanger sequencing of new USH1 exons identified by human retinal transcriptome analysis. RESULTS: With this approach, we were able to genetically solve 14 of the 47 probands by confirming the biallelic inheritance of mutations. We detected two likely pathogenic variants in an additional 19 patients, for whom family members were not available for cosegregation analysis to confirm biallelic inheritance. Ten patients, in addition to primary disease-causing mutations, carried rare likely pathogenic USH1 alleles or variants in other genes associated with deaf-blindness, which may influence disease phenotype. Twenty-one of the identified mutations were novel among the 33 definite or likely solved patients. Here, we also present a clinical description of the studied cohort at their initial visits. CONCLUSIONS: We found a remarkable genetic heterogeneity in the studied USH1 cohort with multiplicity of mutations, of which many were novel. No obvious influence of genotype on phenotype was found, possibly due to small sample sizes of the genotypes under study. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: F Di Palma; R H Holme; E C Bryda; I A Belyantseva; R Pellegrino; B Kachar; K P Steel; K Noben-Trauth Journal: Nat Genet Date: 2001-01 Impact factor: 38.330
Authors: D Weil; S Blanchard; J Kaplan; P Guilford; F Gibson; J Walsh; P Mburu; A Varela; J Levilliers; M D Weston Journal: Nature Date: 1995-03-02 Impact factor: 49.962
Authors: Teresa Jaijo; Elena Aller; Gema García-García; María J Aparisi; Sara Bernal; Almudena Avila-Fernández; Isabel Barragán; Montserrat Baiget; Carmen Ayuso; Guillermo Antiñolo; Manuel Díaz-Llopis; Maigi Külm; Magdalena Beneyto; Carmen Nájera; Jose M Millán Journal: Invest Ophthalmol Vis Sci Date: 2009-08-13 Impact factor: 4.799
Authors: T Hashimoto; D Gibbs; C Lillo; S M Azarian; E Legacki; X-M Zhang; X-J Yang; D S Williams Journal: Gene Ther Date: 2007-02-01 Impact factor: 4.184
Authors: Zubair M Ahmed; Sten Kjellstrom; Ricky J L Haywood-Watson; Ronald A Bush; Lori L Hampton; James F Battey; Saima Riazuddin; Gregory Frolenkov; Paul A Sieving; Thomas B Friedman Journal: Mol Vis Date: 2008-12-08 Impact factor: 2.367
Authors: Thomas Besnard; Gema García-García; David Baux; Christel Vaché; Valérie Faugère; Lise Larrieu; Susana Léonard; Jose M Millan; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux Journal: Mol Genet Genomic Med Date: 2013-07-10 Impact factor: 2.183
Authors: Cindy Ung; Angie V Sanchez; Lishuang Shen; Samaneh Davoudi; Tina Ahmadi; Daniel Navarro-Gomez; Ching J Chen; Heather Hancock; Alan Penman; Suzanne Hoadley; Mark Consugar; Carlos Restrepo; Vinay A Shah; Joseph F Arboleda-Velasquez; Lucia Sobrin; Xiaowu Gai; Leo A Kim Journal: Vision Res Date: 2017-05-09 Impact factor: 1.886
Authors: Christine Neuhaus; Tobias Eisenberger; Christian Decker; Sandra Nagl; Cornelia Blank; Markus Pfister; Ingo Kennerknecht; Cornelie Müller-Hofstede; Peter Charbel Issa; Raoul Heller; Bodo Beck; Klaus Rüther; Diana Mitter; Klaus Rohrschneider; Ute Steinhauer; Heike M Korbmacher; Dagmar Huhle; Solaf M Elsayed; Hesham M Taha; Shahid M Baig; Heidi Stöhr; Markus Preising; Susanne Markus; Fabian Moeller; Birgit Lorenz; Kerstin Nagel-Wolfrum; Arif O Khan; Hanno J Bolz Journal: Mol Genet Genomic Med Date: 2017-07-06 Impact factor: 2.183
Authors: Clara J Men; Kinga M Bujakowska; Jason Comander; Emily Place; Emma C Bedoukian; Xiaosong Zhu; Bart P Leroy; Anne B Fulton; Eric A Pierce Journal: Mol Vis Date: 2017-10-10 Impact factor: 2.367
Authors: Jason Comander; Carol Weigel-DiFranco; Matthew Maher; Emily Place; Aliete Wan; Shyana Harper; Michael A Sandberg; Daniel Navarro-Gomez; Eric A Pierce Journal: Genes (Basel) Date: 2017-10-05 Impact factor: 4.096